Novavax (NVAX)

Company Description

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates.


 

COMPANY ADDRESS
9920 Belward Campus Drive
Rockville, Maryland 20850
United States

COMPANY PHONE
240-268-2000

COMPANY WEBSITE



Get BioInvest's perspective on Novavax's CEO


Latest Company News

2 Sizzling Hot Biotechnology Stocks: Novavax, Inc. (NVAX), Celgene Corporation ... The Independent Republic - 1 hour ago Novavax, Inc. (NVAX) ended last trading session with a change of -3.97 percent. It trades at an average volume of 6.92M shares versus 4.78M shares recorded at the end of last trading session. [...]
Wed, Feb 22, 2017 12:12:00 PM, Continue reading at the source
The Technicals For Novavax, Inc. (NVAX) Tell An Interesting Tale NY Stock News - 17 hours ago The technicals for Novavax, Inc. (NVAX) have taken shape, and with them a comprehensive picture has emerged. This is the current state of play as presented by the current technical setup. [...]
Tue, Feb 21, 2017 7:41:00 PM, Continue reading at the source
Analytical Guide for Novavax, Inc. (NVAX), WPX Energy, Inc. (WPX) Stakeholders The USA Commerce - 19 hours ago Shares of Novavax, Inc. (NASDAQ:NVAX) dropped -3.21% to $1.51. During the trading on 02/17/2017, Company's stock ranged from $1.49 to $1.56. [...]
Tue, Feb 21, 2017 5:40:00 PM, Continue reading at the source
Just the Facts on Novavax, Inc. (NVAX) StockNewsJournal - 22 hours ago Novavax, Inc. (NVAX) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $1.51, down from yesterday's close by -3.21%. Eventide Asset Management LLC Has $1827000 Stake in Novavax, Inc. (NVAX) - Sports Perspectives Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 ... - Yahoo Finance [...]
Tue, Feb 21, 2017 2:58:00 PM, Continue reading at the source
Short Interest in Novavax, Inc. (NVAX) Decreases By 1.9% Chaffey Breeze - Feb 18, 2017 Novavax logo Novavax, Inc. (NASDAQ:NVAX) saw a large decrease in short interest in January. As of January 31st, there was short interest totalling 63,797,973 shares, a decrease of 1.9% from the January 13th total of 65,010,684 shares. Price Target Estimates Under Analyst's Radar: Novavax, Inc. (NASDAQ:NVAX) - Post Registrar The Novavax, Inc. (NVAX) Short Interest Update - DailyQuint [...]
Sat, Feb 18, 2017 12:12:00 PM, Continue reading at the source
Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals Motley Fool - Feb 16, 2017 Nanoparticle vaccine-maker Novavax took a major step backward last year with the late-stage failure of its respiratory syncytial virus (RSV) F vaccine in older adults. [...]
Thu, Feb 16, 2017 3:22:00 PM, Continue reading at the source
Why Novavax, Inc. (NASDAQ:NVAX) Stock Jumped Over 14%? FinancialsTrend - Feb 16, 2017 In the last trading session, the stock price of Novavax, Inc. (NASDAQ:NVAX) gained over 14% to close the session at $1.62 on more than normal volume. Novavax Inc. (NVAX) Moves Lower on Volume Spike for February 16 - Equities.com analysts Estimates and Ratings: Novavax, Inc. (NASDAQ:NVAX) - News Oracle [...]
Thu, Feb 16, 2017 12:00:00 PM, Continue reading at the source
ROI of Novavax, Inc. (NASDAQ:NVAX) stands at -53.6 TopChronicle - Feb 9, 2017 Novavax, Inc. (NASDAQ:NVAX) traded with the volume of 3.48 Million in the previous trading session. The Stock opened its session at $1.29 and closed at $1.31 by showing increase of 0 percent. The Novavax, Inc. (NVAX) Rating Reiterated by FBR & Co - DailyQuint Yesterday Stock's Price Swings: Novavax, Inc. (NASDAQ:NVAX), Centene Corp ... - TRA [...]
Thu, Feb 09, 2017 3:15:00 PM, Continue reading at the source
ROE of Novavax, Inc. (NASDAQ:NVAX) stands at -189.1 TopChronicle - Feb 7, 2017 Novavax, Inc. (NASDAQ:NVAX) traded with the volume of 2.71 Million in the previous trading session. The Stock opened its session at $1.33 and closed at $1.33 by showing increase of 0 percent. Stock Rating Report: Novavax, Inc.'s (NVAX) - Is stories Noteworthy Analyst Ratings of 2 Stocks: EnteroMedics Inc. (NASDAQ:ETRM ... - The Voice Registrar [...]
Tue, Feb 07, 2017 12:45:00 PM, Continue reading at the source
Novavax Inc Risk Points versus Health Care CML News - Jan 28, 2017 This is a scatter plot analysis of the critical risk points from the option market for Novavax Inc (NASDAQ:NVAX) compared to its own past and the Health Care ETF. [...]
Sat, Jan 28, 2017 11:15:00 PM, Continue reading at the source